Trends in secondary prevention of coronary heart disease in Tunisia: prevention of recurrences of MI and stroke. |
, 2012 |
Electronic Journal of Digital Entreprise, 7, Décembre 2012, 361 - 366, Mars 2012 |
Résumé
The survival benefits achieved by prescription of antiplatelet agents, B-adrenoreceptor antagonists (beta-blockers), angiotensin II receptor blockers (ARB), and lipid lowering agents in patients surviving the myocardial infarction (MI) have been well documented in large clinical trial. Despite well-established benefits, these pharmacological agents continue to be underutilized. The main objective of this study was to evaluate the progress of cardiovascular secondary prevention practices in Tunisia.
Actualités
Tél. : 71763709 - Fax : 71795889
Email : informatique@utm.rnu.tn